Cargando…

Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey

Adverse events are frequent in nontuberculous mycobacteria pulmonary disease treatment, but evidence to support their management is scarce. An expert panel survey on management of adverse events shows consistent opinions on management of hepatoxicity, ocular toxicity, ototoxicity, tinnitus, and gast...

Descripción completa

Detalles Bibliográficos
Autores principales: van Ingen, Jakko, Aliberti, Stefano, Andrejak, Claire, Chalmers, James D, Codecasa, Luigi R, Daley, Charles L, Hasegawa, Naoki, Griffith, David E, Hoefsloot, Wouter, Huitt, Gwen, Jarand, Julie, Jhun, Byung Woo, Loebinger, Michael R, Marras, Theodore K, Morimoto, Kozo, Polverino, Eva, Ringshausen, Felix C, Santin, Miguel, Thomson, Rachel, Wagner, Dirk, Wallace, Richard J, Winthrop, Kevin L, Yim, Jae-Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491833/
https://www.ncbi.nlm.nih.gov/pubmed/32910814
http://dx.doi.org/10.1093/cid/ciaa1361
_version_ 1784578808760762368
author van Ingen, Jakko
Aliberti, Stefano
Andrejak, Claire
Chalmers, James D
Codecasa, Luigi R
Daley, Charles L
Hasegawa, Naoki
Griffith, David E
Hoefsloot, Wouter
Huitt, Gwen
Jarand, Julie
Jhun, Byung Woo
Loebinger, Michael R
Marras, Theodore K
Morimoto, Kozo
Polverino, Eva
Ringshausen, Felix C
Santin, Miguel
Thomson, Rachel
Wagner, Dirk
Wallace, Richard J
Winthrop, Kevin L
Yim, Jae-Joon
author_facet van Ingen, Jakko
Aliberti, Stefano
Andrejak, Claire
Chalmers, James D
Codecasa, Luigi R
Daley, Charles L
Hasegawa, Naoki
Griffith, David E
Hoefsloot, Wouter
Huitt, Gwen
Jarand, Julie
Jhun, Byung Woo
Loebinger, Michael R
Marras, Theodore K
Morimoto, Kozo
Polverino, Eva
Ringshausen, Felix C
Santin, Miguel
Thomson, Rachel
Wagner, Dirk
Wallace, Richard J
Winthrop, Kevin L
Yim, Jae-Joon
author_sort van Ingen, Jakko
collection PubMed
description Adverse events are frequent in nontuberculous mycobacteria pulmonary disease treatment, but evidence to support their management is scarce. An expert panel survey on management of adverse events shows consistent opinions on management of hepatoxicity, ocular toxicity, ototoxicity, tinnitus, and gastrointestinal upset. These opinions can provide assistance in individual patient management decisions.
format Online
Article
Text
id pubmed-8491833
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-84918332021-10-06 Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey van Ingen, Jakko Aliberti, Stefano Andrejak, Claire Chalmers, James D Codecasa, Luigi R Daley, Charles L Hasegawa, Naoki Griffith, David E Hoefsloot, Wouter Huitt, Gwen Jarand, Julie Jhun, Byung Woo Loebinger, Michael R Marras, Theodore K Morimoto, Kozo Polverino, Eva Ringshausen, Felix C Santin, Miguel Thomson, Rachel Wagner, Dirk Wallace, Richard J Winthrop, Kevin L Yim, Jae-Joon Clin Infect Dis Online Only Articles Adverse events are frequent in nontuberculous mycobacteria pulmonary disease treatment, but evidence to support their management is scarce. An expert panel survey on management of adverse events shows consistent opinions on management of hepatoxicity, ocular toxicity, ototoxicity, tinnitus, and gastrointestinal upset. These opinions can provide assistance in individual patient management decisions. Oxford University Press 2020-09-10 /pmc/articles/PMC8491833/ /pubmed/32910814 http://dx.doi.org/10.1093/cid/ciaa1361 Text en © The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Online Only Articles
van Ingen, Jakko
Aliberti, Stefano
Andrejak, Claire
Chalmers, James D
Codecasa, Luigi R
Daley, Charles L
Hasegawa, Naoki
Griffith, David E
Hoefsloot, Wouter
Huitt, Gwen
Jarand, Julie
Jhun, Byung Woo
Loebinger, Michael R
Marras, Theodore K
Morimoto, Kozo
Polverino, Eva
Ringshausen, Felix C
Santin, Miguel
Thomson, Rachel
Wagner, Dirk
Wallace, Richard J
Winthrop, Kevin L
Yim, Jae-Joon
Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey
title Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey
title_full Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey
title_fullStr Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey
title_full_unstemmed Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey
title_short Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey
title_sort management of drug toxicity in mycobacterium avium complex pulmonary disease: an expert panel survey
topic Online Only Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491833/
https://www.ncbi.nlm.nih.gov/pubmed/32910814
http://dx.doi.org/10.1093/cid/ciaa1361
work_keys_str_mv AT vaningenjakko managementofdrugtoxicityinmycobacteriumaviumcomplexpulmonarydiseaseanexpertpanelsurvey
AT alibertistefano managementofdrugtoxicityinmycobacteriumaviumcomplexpulmonarydiseaseanexpertpanelsurvey
AT andrejakclaire managementofdrugtoxicityinmycobacteriumaviumcomplexpulmonarydiseaseanexpertpanelsurvey
AT chalmersjamesd managementofdrugtoxicityinmycobacteriumaviumcomplexpulmonarydiseaseanexpertpanelsurvey
AT codecasaluigir managementofdrugtoxicityinmycobacteriumaviumcomplexpulmonarydiseaseanexpertpanelsurvey
AT daleycharlesl managementofdrugtoxicityinmycobacteriumaviumcomplexpulmonarydiseaseanexpertpanelsurvey
AT hasegawanaoki managementofdrugtoxicityinmycobacteriumaviumcomplexpulmonarydiseaseanexpertpanelsurvey
AT griffithdavide managementofdrugtoxicityinmycobacteriumaviumcomplexpulmonarydiseaseanexpertpanelsurvey
AT hoefslootwouter managementofdrugtoxicityinmycobacteriumaviumcomplexpulmonarydiseaseanexpertpanelsurvey
AT huittgwen managementofdrugtoxicityinmycobacteriumaviumcomplexpulmonarydiseaseanexpertpanelsurvey
AT jarandjulie managementofdrugtoxicityinmycobacteriumaviumcomplexpulmonarydiseaseanexpertpanelsurvey
AT jhunbyungwoo managementofdrugtoxicityinmycobacteriumaviumcomplexpulmonarydiseaseanexpertpanelsurvey
AT loebingermichaelr managementofdrugtoxicityinmycobacteriumaviumcomplexpulmonarydiseaseanexpertpanelsurvey
AT marrastheodorek managementofdrugtoxicityinmycobacteriumaviumcomplexpulmonarydiseaseanexpertpanelsurvey
AT morimotokozo managementofdrugtoxicityinmycobacteriumaviumcomplexpulmonarydiseaseanexpertpanelsurvey
AT polverinoeva managementofdrugtoxicityinmycobacteriumaviumcomplexpulmonarydiseaseanexpertpanelsurvey
AT ringshausenfelixc managementofdrugtoxicityinmycobacteriumaviumcomplexpulmonarydiseaseanexpertpanelsurvey
AT santinmiguel managementofdrugtoxicityinmycobacteriumaviumcomplexpulmonarydiseaseanexpertpanelsurvey
AT thomsonrachel managementofdrugtoxicityinmycobacteriumaviumcomplexpulmonarydiseaseanexpertpanelsurvey
AT wagnerdirk managementofdrugtoxicityinmycobacteriumaviumcomplexpulmonarydiseaseanexpertpanelsurvey
AT wallacerichardj managementofdrugtoxicityinmycobacteriumaviumcomplexpulmonarydiseaseanexpertpanelsurvey
AT winthropkevinl managementofdrugtoxicityinmycobacteriumaviumcomplexpulmonarydiseaseanexpertpanelsurvey
AT yimjaejoon managementofdrugtoxicityinmycobacteriumaviumcomplexpulmonarydiseaseanexpertpanelsurvey